Biosimilars Definition Medication Therapy Management (MTM) 
Putting Patients First Blog
DECEMBER 9, 2024
Biosimilars and Generics The formulary inclusion of biosimilars and generics is essential in reducing the costs of medications for Medicare recipients. To enable lower cost medications, CMS would require that plan formularies prioritize access to biosimilars, generics, and affordable other alternatives.
Putting Patients First Blog
JANUARY 27, 2025
To strengthen the proposal, the NHC recommends that CMS avoid implementing rigid definitions of overweight and obese. Instead, CMS should review Part D plan prior authorization criteria to ensure that plan definitions align with treatment guidelines and ICD-10 diagnosis codes, promoting consistency and alignment among providers and payers.
Expert insights. Personalized for you.
52 
Let's personalize your content